• $514,689.00
    Market Cap
  • 100.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
331,645
N/A
N/A
N/A
Cost of Revenue
321,615
-51.39%
661,591
N/A
Gross Profit
10,030
+101.79%
-560,018
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
19,460
-72.16%
69,907
N/A
Total Operating Expenses
846,234
-2.14%
864,768
N/A
Operating Profit
-2.8M
+46.15%
-1.9M
N/A
Interest Income
90,667
+5,080.97%
1,750
N/A
Interest Expense
N/A
N/A
-490,053
N/A
Interest Income and Expense and Net
90,667
+118.57%
-488,303
N/A
Total Nonoperating Income and Expense
-2.0M
+296.80%
-497,144
N/A
Income before Taxes
-2.8M
+46.15%
-1.9M
N/A
Income Taxes
0
+100.00%
-26,937
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-1.9M
N/A
Net Income from Continuing Operations Applicable to Common
-2.8M
+46.15%
-1.9M
N/A
Basic EPS and Net Income
-0.002
+23.08%
-0.001
N/A
Diluted EPS and Net Income
-0.002
+23.08%
-0.001
N/A
Basic Weighted Average Shares
1.8B
+24.36%
1.5B
N/A
Diluted Weighted Average Shares
1.8B
+24.36%
1.5B
N/A
Balance Sheet
Cash and Cash Equivalents
0
-100.00%
6,600
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
0
-100.00%
6,600
N/A
Total Current Assets
257,310
+1.31%
253,993
N/A
Accumulated Depreciation
547,287
+3.69%
527,827
N/A
Property and Plant and Equipment and Net
N/A
N/A
7.4M
N/A
Total Long-Term Assets
N/A
N/A
7.4M
N/A
Total Assets
948,015
-87.63%
7.7M
N/A
Income Taxes Payable
0
N/A
0
N/A
Total Short-Term Debt
562,063
+6.94%
525,609
N/A
Total Current Liabilities
3.6M
-3.31%
3.7M
N/A
Total Long-Term Debt
561,087
-87.05%
4.3M
N/A
Total Long-Term Liabilities
561,087
-87.05%
4.3M
N/A
Total Liabilities
3.6M
-3.31%
3.7M
N/A
Retained Earnings
-5.7M
+97.98%
-2.9M
N/A
Total Stockholders Equity
-3.2M
+700.06%
-402,719
N/A
Total Shares Outstanding
1.6B
+13.26%
1.5B
N/A
Cash Flow
Cash from Operating Activities
-3.0M
+170.49%
-1.1M
N/A
Capital Expenditures
N/A
N/A
15,132
N/A
Cash from Investing Activities
6.7M
+44,491.30%
-15,132
N/A
Dividends Paid
0
N/A
N/A
N/A
Cash from Financing Activities
-3.7M
-429.94%
1.1M
N/A
Financials Ratio
Gross Margin
3.02%
N/A
N/A
N/A
Operating Margin
-846.96%
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
0.07
N/A
N/A
N/A
Cash Ratio
0.00
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.35
N/A
N/A
N/A
Debt-to-Assets Ratio
1.18
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow